APT Medical Inc (688617) - Net Assets

Latest as of September 2025: CN¥3.04 Billion CNY ≈ $444.45 Million USD

Based on the latest financial reports, APT Medical Inc (688617) has net assets worth CN¥3.04 Billion CNY (≈ $444.45 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.46 Billion ≈ $506.42 Million USD) and total liabilities (CN¥423.50 Million ≈ $61.97 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 688617 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥3.04 Billion
% of Total Assets 87.76%
Annual Growth Rate 42.47%
5-Year Change 467.63%
10-Year Change N/A
Growth Volatility 97.63

APT Medical Inc - Net Assets Trend (2017–2024)

This chart illustrates how APT Medical Inc's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of APT Medical Inc for the complete picture of this company's asset base.

Annual Net Assets for APT Medical Inc (2017–2024)

The table below shows the annual net assets of APT Medical Inc from 2017 to 2024. For live valuation and market cap data, see market value of APT Medical Inc.

Year Net Assets Change
2024-12-31 CN¥2.55 Billion
≈ $373.85 Million		 +30.22%
2023-12-31 CN¥1.96 Billion
≈ $287.10 Million		 +9.54%
2022-12-31 CN¥1.79 Billion
≈ $262.09 Million		 +0.00%
2021-12-31 CN¥1.79 Billion
≈ $262.09 Million		 +297.94%
2020-12-31 CN¥450.09 Million
≈ $65.86 Million		 +30.12%
2019-12-31 CN¥345.90 Million
≈ $50.62 Million		 +27.78%
2018-12-31 CN¥270.70 Million
≈ $39.61 Million		 +26.24%
2017-12-31 CN¥214.43 Million
≈ $31.38 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to APT Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1536.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥1.64 Billion 65.02%
Common Stock CN¥97.39 Million 3.87%
Other Comprehensive Income CN¥87.56 Million 3.48%
Other Components CN¥695.25 Million 27.63%
Total Equity CN¥2.52 Billion 100.00%

APT Medical Inc Competitors by Market Cap

The table below lists competitors of APT Medical Inc ranked by their market capitalization.

Company Market Cap
Axos Financial Inc
NYSE:AX
 $4.84 Billion
BRF S.A
F:P5Y
 $4.84 Billion
China International Marine Containers (Group) Co. Ltd
F:OCM
 $4.84 Billion
GS Holdings
KO:078930
 $4.84 Billion
Bancolombia S.A
F:BXK
 $4.84 Billion
Farsoon Technology Co. Ltd. A
SHG:688433
 $4.84 Billion
Celcuity LLC
NASDAQ:CELC
 $4.84 Billion
Choice Hotels International Inc
NYSE:CHH
 $4.83 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in APT Medical Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,907,142,308 to 2,516,339,545, a change of 609,197,237 (31.9%).
  • Net income of 673,151,718 contributed positively to equity growth.
  • Dividend payments of 133,970,528 reduced retained earnings.
  • Other comprehensive income decreased equity by 24,185,590.
  • Other factors increased equity by 94,201,637.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥673.15 Million +26.75%
Dividends Paid CN¥133.97 Million -5.32%
Other Comprehensive Income CN¥-24.19 Million -0.96%
Other Changes CN¥94.20 Million +3.74%
Total Change CN¥- 31.94%

Book Value vs Market Value Analysis

This analysis compares APT Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 9.06x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 54.69x to 9.06x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 CN¥4.29 CN¥234.40 x
2018-12-31 CN¥5.39 CN¥234.40 x
2019-12-31 CN¥5.24 CN¥234.40 x
2020-12-31 CN¥6.90 CN¥234.40 x
2021-12-31 CN¥26.67 CN¥234.40 x
2022-12-31 CN¥26.45 CN¥234.40 x
2023-12-31 CN¥28.43 CN¥234.40 x
2024-12-31 CN¥25.87 CN¥234.40 x

Capital Efficiency Dashboard

This dashboard shows how efficiently APT Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 26.75%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 32.59%
  • • Asset Turnover: 0.69x
  • • Equity Multiplier: 1.18x
  • Recent ROE (26.75%) is above the historical average (19.81%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 16.10% 22.51% 0.61x 1.18x CN¥13.06 Million
2018 7.97% 8.90% 0.74x 1.21x CN¥-5.47 Million
2019 23.62% 20.44% 0.72x 1.60x CN¥47.62 Million
2020 24.06% 23.11% 0.81x 1.28x CN¥64.74 Million
2021 11.69% 25.09% 0.41x 1.13x CN¥30.11 Million
2022 20.30% 29.44% 0.55x 1.26x CN¥181.69 Million
2023 28.00% 32.35% 0.64x 1.35x CN¥343.21 Million
2024 26.75% 32.59% 0.69x 1.18x CN¥421.52 Million

Industry Comparison

This section compares APT Medical Inc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $2,964,235,365
  • Average return on equity (ROE) among peers: 8.35%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
APT Medical Inc (688617) CN¥3.04 Billion 16.10% 0.14x $4.84 Billion
Shanghai Kehua Bio-Engineering Co Ltd (002022) $1.03 Billion 22.10% 0.17x $449.34 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) $10.07 Billion 15.85% 0.50x $4.35 Billion
Double Medical Technology Inc (002901) $3.18 Billion 11.21% 0.39x $2.60 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) $615.62 Million 6.75% 0.04x $571.62 Million
Lepu Medical Tech Beijing (300003) $6.58 Billion 18.53% 1.30x $3.90 Billion
INKON Life Technology Co Ltd (300143) $1.48 Billion 0.71% 0.25x $1.25 Billion
Edan Instruments Inc (300206) $1.16 Billion 1.16% 0.17x $1.28 Billion
Guangdong Biolight Meditech Co Ltd (300246) $1.50 Billion 1.47% 0.62x $696.90 Million
Beijing Leadman Biochemistry Co Ltd (300289) $1.38 Billion -3.70% 0.18x $533.36 Million
Sinocare Inc (300298) $2.65 Billion 9.46% 0.24x $1.35 Billion

About APT Medical Inc

SHG:688617 China Medical Devices
Market Cap
$4.84 Billion
CN¥33.06 Billion CNY
Market Cap Rank
#3688 Global
#585 in China
Share Price
CN¥234.40
Change (1 day)
-1.46%
52-Week Range
CN¥221.50 - CN¥419.86
All Time High
CN¥453.00
Categories
Companies in China Medical Devices
About

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and acces… Read more